What Researchers Did
Researchers conducted a randomized controlled trial to assess the effect of preoperative hyperbaric oxygen therapy on patients undergoing pancreaticoduodenectomy.
What They Found
Of 33 patients, 17 received preoperative HBO2 and 16 did not. While most inflammatory markers showed no statistical differences, patients receiving HBO2 had lower pain levels on postoperative day 30 (VAS score 1 ± 1.3 vs. 3 ± 3.0, p=0.05) and a lower percentage of positive lymph nodes (7% vs. 14%, p<0.001).
What This Means for Canadian Patients
For Canadian patients undergoing pancreaticoduodenectomy, preoperative hyperbaric oxygen therapy might potentially reduce postoperative pain and the incidence of positive lymph nodes. However, further research is needed to confirm these benefits and assess long-term outcomes.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
The study was limited by a small sample size and the abstract did not provide complete information on overall survival outcomes.